{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:02:59Z","timestamp":1790996579452,"version":"4.1.0"},"reference-count":115,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071422"],"award-info":[{"award-number":["82071422"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271459"],"award-info":[{"award-number":["82271459"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["7212031"],"award-info":[{"award-number":["7212031"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s00415-025-12894-8","type":"journal-article","created":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T14:54:21Z","timestamp":1738421661000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Dopaminergic responsiveness and dopaminergic challenge tests of Parkinson\u2019s disease: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"272","author":[{"given":"Wenyi","family":"Kou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huihui","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusha","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinqiao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,1]]},"reference":[{"issue":"9996","key":"12894_CR1","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/s0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia LV, Lang AE (2015) Parkinson\u2019s disease. Lancet 386(9996):896\u2013912. https:\/\/doi.org\/10.1016\/s0140-6736(14)61393-3","journal-title":"Lancet"},{"key":"12894_CR2","doi-asserted-by":"publisher","first-page":"17013","DOI":"10.1038\/nrdp.2017.13","volume":"3","author":"W Poewe","year":"2017","unstructured":"Poewe W, Seppi K, Tanner CM, Halliday GM, Brundin P, Volkmann J et al (2017) Parkinson Dis Nat Rev Dis Primers 3:17013. https:\/\/doi.org\/10.1038\/nrdp.2017.13","journal-title":"Parkinson Dis Nat Rev Dis Primers"},{"key":"12894_CR3","doi-asserted-by":"publisher","unstructured":"Constantinescu R, Richard I, Kurlan R. Levodopa responsiveness in disorders with parkinsonism: a review of the literature. Mov Disord. 2007;22(15):2141\u20138; quiz 295. https:\/\/doi.org\/10.1002\/mds.21578","DOI":"10.1002\/mds.21578"},{"issue":"12","key":"12894_CR4","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W et al (2015) MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord 30(12):1591\u20131601. https:\/\/doi.org\/10.1002\/mds.26424","journal-title":"Mov Disord"},{"issue":"Suppl 3","key":"12894_CR5","doi-asserted-by":"publisher","first-page":"S94","DOI":"10.1002\/mds.10149","volume":"17","author":"AE Lang","year":"2002","unstructured":"Lang AE, Widner H (2002) Deep brain stimulation for Parkinson\u2019s disease: patient selection and evaluation. Mov Disord 17(Suppl 3):S94-101. https:\/\/doi.org\/10.1002\/mds.10149","journal-title":"Mov Disord"},{"issue":"9","key":"12894_CR6","doi-asserted-by":"publisher","first-page":"3135","DOI":"10.1007\/s00415-020-09810-7","volume":"268","author":"G Saranza","year":"2021","unstructured":"Saranza G, Lang AE (2021) Levodopa challenge test: indications, protocol, and guide. J Neurol 268(9):3135\u20133143. https:\/\/doi.org\/10.1007\/s00415-020-09810-7","journal-title":"J Neurol"},{"issue":"Suppl 3","key":"12894_CR7","doi-asserted-by":"publisher","first-page":"S521","DOI":"10.1002\/mds.22049","volume":"23","author":"K Sethi","year":"2008","unstructured":"Sethi K (2008) Levodopa unresponsive symptoms in Parkinson disease. Mov Disord 23(Suppl 3):S521\u2013S533. https:\/\/doi.org\/10.1002\/mds.22049","journal-title":"Mov Disord"},{"issue":"12","key":"12894_CR8","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1007\/s00702-005-0379-0","volume":"112","author":"C Colosimo","year":"2005","unstructured":"Colosimo C, Tiple D, Wenning GK (2005) Management of multiple system atrophy: state of the art. J Neural Transm (Vienna) 112(12):1695\u20131704. https:\/\/doi.org\/10.1007\/s00702-005-0379-0","journal-title":"J Neural Transm (Vienna)"},{"issue":"Pt 6","key":"12894_CR9","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1093\/brain\/awh488","volume":"128","author":"DR Williams","year":"2005","unstructured":"Williams DR, de Silva R, Paviour DC, Pittman A, Watt HC, Kilford L et al (2005) Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson\u2019s syndrome and PSP-parkinsonism. Brain 128(Pt 6):1247\u20131258. https:\/\/doi.org\/10.1093\/brain\/awh488","journal-title":"Brain"},{"issue":"8","key":"12894_CR10","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1001\/archneur.55.8.1099","volume":"55","author":"K Kompoliti","year":"1998","unstructured":"Kompoliti K, Goetz CG, Litvan I, Jellinger K, Verny M (1998) Pharmacological therapy in progressive supranuclear palsy. Arch Neurol 55(8):1099\u20131102. https:\/\/doi.org\/10.1001\/archneur.55.8.1099","journal-title":"Arch Neurol"},{"issue":"1","key":"12894_CR11","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/0022-510x(71)90256-5","volume":"12","author":"O Abramsky","year":"1971","unstructured":"Abramsky O, Lavy S, Carmon A (1971) A test for objective evaluation of motor performance in patients receiving L-dopa for Parkinson\u2019s disease. J Neurol Sci 12(1):105\u2013108. https:\/\/doi.org\/10.1016\/0022-510x(71)90256-5","journal-title":"J Neurol Sci"},{"issue":"5","key":"12894_CR12","first-page":"413","volume":"141","author":"M Esteguy","year":"1985","unstructured":"Esteguy M, Bonnet A, Kefalos J, Lhermitte F, Agid Y (1985) Le test \u00e0 la L-dopa dans la maladie de Parkinson. Revue Neurologique (Paris) 141(5):413\u2013415","journal-title":"Revue Neurologique (Paris)"},{"issue":"8639","key":"12894_CR13","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/s0140-6736(89)92183-1","volume":"1","author":"R Barker","year":"1989","unstructured":"Barker R, Duncan J, Lees A (1989) Subcutaneous apomorphine as a diagnostic test for dopaminergic responsiveness in parkinsonian syndromes. Lancet 1(8639):675. https:\/\/doi.org\/10.1016\/s0140-6736(89)92183-1","journal-title":"Lancet"},{"issue":"2","key":"12894_CR14","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1097\/WNF.0b013e318211f945","volume":"34","author":"D Contrafatto","year":"2011","unstructured":"Contrafatto D, Mostile G, Nicoletti A, Raciti L, Luca A, Dibilio V et al (2011) Single photon emission computed tomography striatal asymmetry index may predict dopaminergic responsiveness in Parkinson disease. Clin Neuropharmacol 34(2):71\u201373. https:\/\/doi.org\/10.1097\/WNF.0b013e318211f945","journal-title":"Clin Neuropharmacol"},{"issue":"5","key":"12894_CR15","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1136\/jnnp.69.5.590","volume":"69","author":"CE Clarke","year":"2000","unstructured":"Clarke CE, Davies P (2000) Systematic review of acute levodopa and apomorphine challenge tests in the diagnosis of idiopathic Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 69(5):590\u2013594. https:\/\/doi.org\/10.1136\/jnnp.69.5.590","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"12894_CR16","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https:\/\/doi.org\/10.1136\/bmj.n71","journal-title":"BMJ"},{"issue":"3","key":"12894_CR17","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","volume":"55","author":"AJ Hughes","year":"1992","unstructured":"Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson\u2019s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55(3):181\u2013184. https:\/\/doi.org\/10.1136\/jnnp.55.3.181","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"12894_CR18","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1001\/archneur.56.1.33","volume":"56","author":"DJ Gelb","year":"1999","unstructured":"Gelb DJ, Oliver E, Gilman S (1999) Diagnostic criteria for Parkinson disease. Arch Neurol 56(1):33\u201339. https:\/\/doi.org\/10.1001\/archneur.56.1.33","journal-title":"Arch Neurol"},{"issue":"2","key":"12894_CR19","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1136\/jnnp-2021-327098","volume":"93","author":"JJ Loan","year":"2022","unstructured":"Loan JJ, Kirby C, Emelianova K, Dando OR, Poon MT, Pimenova L et al (2022) Secondary injury and inflammation after intracerebral haemorrhage: a systematic review and meta-analysis of molecular markers in patient brain tissue. J Neurol Neurosurg Psychiatry 93(2):126\u2013132. https:\/\/doi.org\/10.1136\/jnnp-2021-327098","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"9","key":"12894_CR20","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1046\/j.1445-2197.2003.02748.x","volume":"73","author":"K Slim","year":"2003","unstructured":"Slim K, Nini E, Forestier D, Kwiatkowski F, Panis Y, Chipponi J (2003) Methodological index for non-randomized studies (minors): development and validation of a new instrument. ANZ J Surg 73(9):712\u2013716. https:\/\/doi.org\/10.1046\/j.1445-2197.2003.02748.x","journal-title":"ANZ J Surg"},{"issue":"8","key":"12894_CR21","doi-asserted-by":"publisher","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","volume":"155","author":"PF Whiting","year":"2011","unstructured":"Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB et al (2011) QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 155(8):529\u2013536. https:\/\/doi.org\/10.7326\/0003-4819-155-8-201110180-00009","journal-title":"Ann Intern Med"},{"issue":"5","key":"12894_CR22","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1002\/jrsm.1429","volume":"11","author":"J Shi","year":"2020","unstructured":"Shi J, Luo D, Weng H, Zeng XT, Lin L, Chu H et al (2020) Optimally estimating the sample standard deviation from the five-number summary. Res Synth Methods 11(5):641\u2013654. https:\/\/doi.org\/10.1002\/jrsm.1429","journal-title":"Res Synth Methods"},{"issue":"2","key":"12894_CR23","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/jrsm.12","volume":"1","author":"M Borenstein","year":"2010","unstructured":"Borenstein M, Hedges LV, Higgins JP, Rothstein HR (2010) A basic introduction to fixed-effect and random-effects models for meta-analysis. Res Synth Methods 1(2):97\u2013111. https:\/\/doi.org\/10.1002\/jrsm.12","journal-title":"Res Synth Methods"},{"key":"12894_CR24","unstructured":"Dwamena B. MIDAS: Stata module for meta-analytical integration of diagnostic test accuracy studies. 2009."},{"key":"12894_CR25","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.ijcard.2016.07.031","volume":"221","author":"N Dai","year":"2016","unstructured":"Dai N, Zhang X, Zhang Y, Hou L, Li W, Fan B et al (2016) Enhanced diagnostic utility achieved by myocardial blood analysis: A meta-analysis of noninvasive cardiac imaging in the detection of functional coronary artery disease. Int J Cardiol 221:665\u2013673. https:\/\/doi.org\/10.1016\/j.ijcard.2016.07.031","journal-title":"Int J Cardiol"},{"issue":"7414","key":"12894_CR26","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414):557\u2013560. https:\/\/doi.org\/10.1136\/bmj.327.7414.557","journal-title":"BMJ"},{"key":"12894_CR27","volume-title":"Cochrane handbook for systematic reviews of interventions","author":"J Chandler","year":"2019","unstructured":"Chandler J, Cumpston M, Li T, Page MJ, Welch V (2019) Cochrane handbook for systematic reviews of interventions. Wiley, Hoboken"},{"issue":"7109","key":"12894_CR28","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629\u2013634. https:\/\/doi.org\/10.1136\/bmj.315.7109.629","journal-title":"BMJ"},{"issue":"9","key":"12894_CR29","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.jclinepi.2005.01.016","volume":"58","author":"JJ Deeks","year":"2005","unstructured":"Deeks JJ, Macaskill P, Irwig L (2005) The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. J Clin Epidemiol 58(9):882\u2013893. https:\/\/doi.org\/10.1016\/j.jclinepi.2005.01.016","journal-title":"J Clin Epidemiol"},{"issue":"7454","key":"12894_CR30","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","volume":"328","author":"D Atkins","year":"2004","unstructured":"Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S et al (2004) Grading quality of evidence and strength of recommendations. BMJ 328(7454):1490. https:\/\/doi.org\/10.1136\/bmj.328.7454.1490","journal-title":"BMJ"},{"key":"12894_CR31","doi-asserted-by":"publisher","unstructured":"Sch\u00fcnemann HJ, Mustafa RA, Brozek J, Steingart KR, Leeflang M, Murad MH, et al. GRADE guidelines: 21 part 1. Study design, risk of bias, and indirectness in rating the certainty across a body of evidence for test accuracy. J Clin Epidemiol. 2020;122:129\u201341. https:\/\/doi.org\/10.1016\/j.jclinepi.2019.12.020","DOI":"10.1016\/j.jclinepi.2019.12.020"},{"key":"12894_CR32","doi-asserted-by":"publisher","unstructured":"Sch\u00fcnemann HJ, Mustafa RA, Brozek J, Steingart KR, Leeflang M, Murad MH, et al. GRADE guidelines: 21 part 2. Test accuracy: inconsistency, imprecision, publication bias, and other domains for rating the certainty of evidence and presenting it in evidence profiles and summary of findings tables. J Clin Epidemiol. 2020;122:142\u201352. https:\/\/doi.org\/10.1016\/j.jclinepi.2019.12.021","DOI":"10.1016\/j.jclinepi.2019.12.021"},{"issue":"1","key":"12894_CR33","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1136\/jnnp.56.1.65","volume":"56","author":"R Durso","year":"1993","unstructured":"Durso R, Isaac K, Perry L, Saint-Hilaire M, Feldman RG (1993) Age influences magnitude but not duration of response to levodopa. J Neurol Neurosurg Psychiatry 56(1):65\u201368. https:\/\/doi.org\/10.1136\/jnnp.56.1.65","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"12894_CR34","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1097\/00002826-199706000-00008","volume":"20","author":"V Fetoni","year":"1997","unstructured":"Fetoni V, Genitrini S, Monza D, Soliveri P, Testa D, Caraceni T et al (1997) Variations in axial, proximal, and distal motor response to L-dopa in multisystem atrophy and Parkinson\u2019s disease. Clin Neuropharmacol 20(3):239\u2013244. https:\/\/doi.org\/10.1097\/00002826-199706000-00008","journal-title":"Clin Neuropharmacol"},{"issue":"9","key":"12894_CR35","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1001\/archneur.58.9.1385","volume":"58","author":"RB Dewey","year":"2001","unstructured":"Dewey RB, Hutton JT, LeWitt PA, Factor SA (2001) A randomized, double-blind, placebo-controlled trial of subcutaneously injected apomorphine for parkinsonian off-state events. Arch Neurol 58(9):1385\u20131392. https:\/\/doi.org\/10.1001\/archneur.58.9.1385","journal-title":"Arch Neurol"},{"issue":"6","key":"12894_CR36","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1034\/j.1600-0404.2003.00161.x","volume":"108","author":"M Joebges","year":"2003","unstructured":"Joebges M, Mrowka M, Schimke N, Shing M, Dengler R, Odin P (2003) Three-dimensional computerized analysis of diadochokinetic movements of Parkinsonian patients. Acta Neurol Scand 108(6):415\u2013423. https:\/\/doi.org\/10.1034\/j.1600-0404.2003.00161.x","journal-title":"Acta Neurol Scand"},{"issue":"2","key":"12894_CR37","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1111\/j.1468-1331.2004.00942.x","volume":"12","author":"A Bartolic","year":"2005","unstructured":"Bartolic A, Pirtosek Z, Rozman J, Ribaric S (2005) Postural stability of Parkinson\u2019s disease patients is improved by decreasing rigidity. Eur J Neurol 12(2):156\u2013159. https:\/\/doi.org\/10.1111\/j.1468-1331.2004.00942.x","journal-title":"Eur J Neurol"},{"issue":"6","key":"12894_CR38","doi-asserted-by":"publisher","first-page":"3248","DOI":"10.1152\/jn.00697.2006","volume":"96","author":"M Weinberger","year":"2006","unstructured":"Weinberger M, Mahant N, Hutchison WD, Lozano AM, Moro E, Hodaie M et al (2006) Beta oscillatory activity in the subthalamic nucleus and its relation to dopaminergic response in Parkinson\u2019s disease. J Neurophysiol 96(6):3248\u20133256. https:\/\/doi.org\/10.1152\/jn.00697.2006","journal-title":"J Neurophysiol"},{"issue":"5","key":"12894_CR39","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1002\/mds.21903","volume":"23","author":"E Lohmann","year":"2008","unstructured":"Lohmann E, Welter ML, Fraix V, Krack P, Lesage S, Laine S et al (2008) Are parkin patients particularly suited for deep-brain stimulation? Mov Disord 23(5):740\u2013743. https:\/\/doi.org\/10.1002\/mds.21903","journal-title":"Mov Disord"},{"issue":"5","key":"12894_CR40","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.parkreldis.2008.08.010","volume":"15","author":"T Feng","year":"2009","unstructured":"Feng T, Li W, Lu L, Wang Y, Shi W, Zhang J et al (2009) Acute stepwise challenge test with levodopa in treated patients with parkinsonism. Parkinsonism Relat Disord 15(5):354\u2013358. https:\/\/doi.org\/10.1016\/j.parkreldis.2008.08.010","journal-title":"Parkinsonism Relat Disord"},{"issue":"2","key":"12894_CR41","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s00702-009-0351-5","volume":"117","author":"S Skodda","year":"2010","unstructured":"Skodda S, Visser W, Schlegel U (2010) Short- and long-term dopaminergic effects on dysarthria in early Parkinson\u2019s disease. J Neural Transm 117(2):197\u2013205. https:\/\/doi.org\/10.1007\/s00702-009-0351-5","journal-title":"J Neural Transm"},{"key":"12894_CR42","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.bbr.2013.09.032","volume":"257","author":"NS Miller","year":"2013","unstructured":"Miller NS, Kwak Y, Bohnen NI, M\u00fcller MLTM, Dayalu P, Seidler RD (2013) The pattern of striatal dopaminergic denervation explains sensorimotor synchronization accuracy in Parkinson\u2019s disease. Behav Brain Res 257:100\u2013110. https:\/\/doi.org\/10.1016\/j.bbr.2013.09.032","journal-title":"Behav Brain Res"},{"issue":"2","key":"12894_CR43","doi-asserted-by":"publisher","first-page":"107","DOI":"10.5301\/JABFM.2012.9265","volume":"12","author":"M Galli","year":"2014","unstructured":"Galli M, Vimercati SL, Manetti E, Cimolin V, Albertini G, De Pandis MF (2014) Spiral analysis in subjects with parkinson\u2019s disease before and after levodopa treatment: a new protocol with stereophotogrammetric systems. J Appl Biomater Funct Mater 12(2):107\u2013112. https:\/\/doi.org\/10.5301\/JABFM.2012.9265","journal-title":"J Appl Biomater Funct Mater"},{"key":"12894_CR44","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.1381","volume":"3","author":"Y Chen","year":"2015","unstructured":"Chen Y, Pressman P, Simuni T, Parrish TB, Gitelman DR (2015) Effects of acute levodopa challenge on resting cerebral blood flow in Parkinson\u2019s Disease patients assessed using pseudo-continuous arterial spin labeling. PeerJ 3:e1381. https:\/\/doi.org\/10.7717\/peerj.1381","journal-title":"PeerJ"},{"issue":"2","key":"12894_CR45","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.gaitpost.2014.11.008","volume":"41","author":"MF Gago","year":"2015","unstructured":"Gago MF, Fernandes V, Ferreira J, Silva H, Rodrigues ML, Rocha L et al (2015) The effect of levodopa on postural stability evaluated by wearable inertial measurement units for idiopathic and vascular Parkinson\u2019s disease. Gait Posture 41(2):459\u2013464. https:\/\/doi.org\/10.1016\/j.gaitpost.2014.11.008","journal-title":"Gait Posture"},{"key":"12894_CR46","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3389\/fneur.2016.00097","volume":"7","author":"D Aygun","year":"2016","unstructured":"Aygun D, Kocabicak E, Yildiz MO, Temel Y (2016) Effect of Age and Disease Duration on the Levodopa Response in Patients with Advanced Parkinson\u2019s Disease for Deep Brain Stimulation of the Subthalamic Nucleus. Front Neurol 7:97. https:\/\/doi.org\/10.3389\/fneur.2016.00097","journal-title":"Front Neurol"},{"issue":"4","key":"12894_CR47","doi-asserted-by":"publisher","first-page":"779","DOI":"10.3233\/jpd-160906","volume":"6","author":"C Rabel","year":"2016","unstructured":"Rabel C, Le Goff F, Lefaucheur R, Ozel G, Fetter D, Rouille A et al (2016) Subjective perceived motor improvement after acute levodopa challenge in Parkinson\u2019s disease. J Parkinsons Dis 6(4):779\u2013785. https:\/\/doi.org\/10.3233\/jpd-160906","journal-title":"J Parkinsons Dis"},{"issue":"9","key":"12894_CR48","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1002\/mds.26687","volume":"31","author":"M Rossi","year":"2016","unstructured":"Rossi M, Escobar AM, Bril A, Millar Vernetti P, De Palo JI, Cerquetti D et al (2016) Motor features in Parkinson\u2019s disease with normal olfactory function. Mov Disord 31(9):1414\u20131417. https:\/\/doi.org\/10.1002\/mds.26687","journal-title":"Mov Disord"},{"issue":"5","key":"12894_CR49","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1002\/mdc3.12511","volume":"4","author":"S Schade","year":"2017","unstructured":"Schade S, Sixel-D\u00f6ring F, Ebentheuer J, Schulz X, Trenkwalder C, Mollenhauer B (2017) Acute levodopa challenge test in patients with de novo Parkinson\u2019s disease: data from the DeNoPa cohort. Mov Disord Clin Pract 4(5):755\u2013762. https:\/\/doi.org\/10.1002\/mdc3.12511","journal-title":"Mov Disord Clin Pract"},{"issue":"6","key":"12894_CR50","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1002\/mdc3.12517","volume":"4","author":"C Terroba Chambi","year":"2017","unstructured":"Terroba Chambi C, Rossi M, Bril A, Vernetti PM, Cerquetti D, Cammarota A et al (2017) Diagnostic value of combined acute levodopa challenge and olfactory testing to predict Parkinson\u2019s disease. Mov Disord Clin Pract 4(6):824\u2013828. https:\/\/doi.org\/10.1002\/mdc3.12517","journal-title":"Mov Disord Clin Pract"},{"issue":"2","key":"12894_CR51","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1371\/journal.pone.0172145","volume":"12","author":"R Vasta","year":"2017","unstructured":"Vasta R, Nicoletti A, Mostile G, Dibilio V, Sciacca G, Contrafatto D et al (2017) Side effects induced by the acute levodopa challenge in Parkinson\u2019s disease and atypical parkinsonisms. PLoS ONE 12(2):6. https:\/\/doi.org\/10.1371\/journal.pone.0172145","journal-title":"PLoS ONE"},{"issue":"3","key":"12894_CR52","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/cns.12670","volume":"23","author":"H Zach","year":"2017","unstructured":"Zach H, Dirkx MF, Pasman JW, Bloem BR, Helmich RC (2017) Cognitive stress reduces the effect of Levodopa on Parkinson\u2019s resting tremor. CNS Neurosci Ther 23(3):209\u2013215. https:\/\/doi.org\/10.1111\/cns.12670","journal-title":"CNS Neurosci Ther"},{"key":"12894_CR53","doi-asserted-by":"publisher","first-page":"260","DOI":"10.3389\/fneur.2018.00260","volume":"9","author":"M Pieterman","year":"2018","unstructured":"Pieterman M, Adams S, Jog M (2018) Method of levodopa response calculation determines strength of association with clinical factors in Parkinson disease. Front Neurol 9:260. https:\/\/doi.org\/10.3389\/fneur.2018.00260","journal-title":"Front Neurol"},{"issue":"1","key":"12894_CR54","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3233\/jpd-171181","volume":"8","author":"K Rosqvist","year":"2018","unstructured":"Rosqvist K, Horne M, Hagell P, Iwarsson S, Nilsson MH, Odin P (2018) Levodopa effect and motor function in late stage Parkinson\u2019s disease. J Parkinsons Dis 8(1):59\u201370. https:\/\/doi.org\/10.3233\/jpd-171181","journal-title":"J Parkinsons Dis"},{"issue":"6","key":"12894_CR55","doi-asserted-by":"publisher","first-page":"2362","DOI":"10.1111\/ejn.14114","volume":"48","author":"F Turco","year":"2018","unstructured":"Turco F, Canessa A, Olivieri C, Pozzi NG, Palmisano C, Arnulfo G et al (2018) Cortical response to levodopa in Parkinson\u2019s disease patients with dyskinesias. Eur J Neurosci 48(6):2362\u20132373. https:\/\/doi.org\/10.1111\/ejn.14114","journal-title":"Eur J Neurosci"},{"key":"12894_CR56","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.parkreldis.2018.10.019","volume":"61","author":"M Wilken","year":"2019","unstructured":"Wilken M, Rossi MD, Rivero AD, Hallett M, Merello M (2019) Latency of re-emergent tremor in Parkinson\u2019s disease is influenced by levodopa. Parkinsonism Relat Disord 61:166\u2013169. https:\/\/doi.org\/10.1016\/j.parkreldis.2018.10.019","journal-title":"Parkinsonism Relat Disord"},{"key":"12894_CR57","doi-asserted-by":"publisher","unstructured":"de Freitas PB, Freitas S, Reschechtko S, Corson T, Lewis MM, Huang XM, et al. Synergic control of action in levodopa-naive Parkinson's disease patients: I. Multi-finger interaction and coordination. Exp Brain Res. 2020;238(1):229\u201345. https:\/\/doi.org\/10.1007\/s00221-019-05709-6","DOI":"10.1007\/s00221-019-05709-6"},{"key":"12894_CR58","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.778856","volume":"13","author":"X He","year":"2021","unstructured":"He X, Mo C, Zhang Y, Cai Y, Yang X, Qian Y et al (2021) Effect of acute levodopa up-titration on blood pressure in patients with early stage Parkinson\u2019s disease: results of a Levodopa challenge test. Front Aging Neurosci 13:778856. https:\/\/doi.org\/10.3389\/fnagi.2021.778856","journal-title":"Front Aging Neurosci"},{"key":"12894_CR59","doi-asserted-by":"publisher","DOI":"10.3389\/fnhum.2021.667997","volume":"15","author":"A Jain","year":"2021","unstructured":"Jain A, Abedinpour K, Polat O, \u00c7al\u0131\u015fkan MM, Asaei A, Pfister FMJ et al (2021) Voice Analysis to Differentiate the Dopaminergic Response in People With Parkinson\u2019s Disease. Front Hum Neurosci 15:667997. https:\/\/doi.org\/10.3389\/fnhum.2021.667997","journal-title":"Front Hum Neurosci"},{"key":"12894_CR60","doi-asserted-by":"publisher","first-page":"4762027","DOI":"10.1155\/2021\/4762027","volume":"2021","author":"Z Zheng","year":"2021","unstructured":"Zheng Z, Yin Z, Zhang B, Fan H, Liu D, Zhou Y et al (2021) Levodopa challenge test predicts STN-DBS outcomes in various Parkinson\u2019s disease motor subtypes: a more accurate judgment. Neural Plast 2021:4762027. https:\/\/doi.org\/10.1155\/2021\/4762027","journal-title":"Neural Plast"},{"issue":"7","key":"12894_CR61","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1097\/wnr.0000000000001641","volume":"32","author":"W Zhou","year":"2021","unstructured":"Zhou W, Jiang J, Peng W, Zhou X, Du J, Mo L et al (2021) Levodopa responsiveness in Parkinson\u2019s disease patients and white matter alterations in diffusion tensor imaging: a cross-sectional tract-based spatial statistics study. NeuroReport 32(7):636\u2013642. https:\/\/doi.org\/10.1097\/wnr.0000000000001641","journal-title":"NeuroReport"},{"key":"12894_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurom.2022.01.013","author":"H Jergas","year":"2022","unstructured":"Jergas H, Petry-Schmelzer JN, Dembek TA, Dafsari HS, Visser-Vandewalle V, Fink GR et al (2022) Brain Morphometry Associated With Response to Levodopa and Deep Brain Stimulation in Parkinson Disease. Neuromodulation. https:\/\/doi.org\/10.1016\/j.neurom.2022.01.013","journal-title":"Neuromodulation"},{"issue":"1","key":"12894_CR63","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/s41531-022-00401-z","volume":"8","author":"N Schr\u00f6ter","year":"2022","unstructured":"Schr\u00f6ter N, Rijntjes M, Urbach H, Weiller C, Treppner M, Kellner E et al (2022) Disentangling nigral and putaminal contribution to motor impairment and levodopa response in Parkinson\u2019s disease. NPJ Parkinsons Dis 8(1):132. https:\/\/doi.org\/10.1038\/s41531-022-00401-z","journal-title":"NPJ Parkinsons Dis"},{"issue":"1","key":"12894_CR64","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41531-022-00286-y","volume":"8","author":"T Tykalova","year":"2022","unstructured":"Tykalova T, Novotny M, Ruzicka E, Dusek P, Rusz J (2022) Short-term effect of dopaminergic medication on speech in early-stage Parkinson\u2019s disease. NPJ Parkinsons Dis 8(1):22. https:\/\/doi.org\/10.1038\/s41531-022-00286-y","journal-title":"NPJ Parkinsons Dis"},{"key":"12894_CR65","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.0000000000201204","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, He X, Mo C, Liu X, Li J, Yan Z et al (2022) Association Between Microbial Tyrosine Decarboxylase Gene and Levodopa Responsiveness in Patients With Parkinson Disease. Neurology. https:\/\/doi.org\/10.1212\/wnl.0000000000201204","journal-title":"Neurology"},{"issue":"5","key":"12894_CR66","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.1007\/s10072-021-05694-1","volume":"43","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Liu G, Wang D, Chen H, Su D, Kou W et al (2022) Effect of onset age on the levodopa threshold dosage for dyskinesia in Parkinson\u2019s disease. Neurol Sci 43(5):3165\u20133174. https:\/\/doi.org\/10.1007\/s10072-021-05694-1","journal-title":"Neurol Sci"},{"issue":"9","key":"12894_CR67","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000033161","volume":"102","author":"D Su","year":"2023","unstructured":"Su D, Su Y, Xu B, Chhetri JK, Chan P (2023) Age as a risk factor for orthostatic hypotension induced by the levodopa challenge test in patients with Parkinson\u2019s disease: Results from a single-center trial. Medicine (Baltimore) 102(9):e33161. https:\/\/doi.org\/10.1097\/md.0000000000033161","journal-title":"Medicine (Baltimore)"},{"issue":"8706","key":"12894_CR68","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/0140-6736(90)91531-e","volume":"336","author":"AJ Hughes","year":"1990","unstructured":"Hughes AJ, Lees AJ, Stern GM (1990) Apomorphine test to predict dopaminergic responsiveness in parkinsonian syndromes. Lancet 336(8706):32\u201334. https:\/\/doi.org\/10.1016\/0140-6736(90)91531-e","journal-title":"Lancet"},{"issue":"10","key":"12894_CR69","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1136\/jnnp.54.10.870","volume":"54","author":"DF D'Costa","year":"1991","unstructured":"D\u2019Costa DF, Abbott RJ, Pye IF, Millac PA (1991) The apomorphine test in parkinsonian syndromes. J Neurol Neurosurg Psychiatry 54(10):870\u2013872. https:\/\/doi.org\/10.1136\/jnnp.54.10.870","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"12894_CR70","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1002\/mds.870080207","volume":"8","author":"U Bonuccelli","year":"1993","unstructured":"Bonuccelli U, Piccini P, Del Dotto P, Rossi G, Corsini GU, Muratorio A (1993) Apomorphine test for dopaminergic responsiveness: a dose assessment study. Mov Disord 8(2):158\u2013164. https:\/\/doi.org\/10.1002\/mds.870080207","journal-title":"Mov Disord"},{"issue":"9","key":"12894_CR71","first-page":"288","volume":"8","author":"G Linazasoro","year":"1993","unstructured":"Linazasoro G (1993) The apomorphine test in the Parkinson syndromes: Diagnostic value. Neurologia 8(9):288\u2013289","journal-title":"Neurologia"},{"issue":"2","key":"12894_CR72","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1097\/00002826-199304000-00006","volume":"16","author":"EA Parati","year":"1993","unstructured":"Parati EA, Fetoni V, Geminiani GC, Soliveri P, Giovannini P, Testa D et al (1993) Response to L-DOPA in multiple system atrophy. Clin Neuropharmacol 16(2):139\u2013144. https:\/\/doi.org\/10.1097\/00002826-199304000-00006","journal-title":"Clin Neuropharmacol"},{"issue":"4","key":"12894_CR73","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1002\/mds.870080406","volume":"8","author":"L Schelosky","year":"1993","unstructured":"Schelosky L, Hierholzer J, Wissel J, Cordes M, Poewe W (1993) Correlation of clinical response in apomorphine test with D2-receptor status as demonstrated by 123I IBZM-SPECT. Mov Disord 8(4):453\u2013458. https:\/\/doi.org\/10.1002\/mds.870080406","journal-title":"Mov Disord"},{"key":"12894_CR74","unstructured":"Schwarz J, Tatsch K, Arnold G, Ott M, Trenkwalder C, Kirsch CM, et al. 123I-iodobenzamide-SPECT in 83 patients with de novo parkinsonism. Neurology. 1993;43(12 II SUPPL. 6):S17-S20."},{"issue":"21","key":"12894_CR75","first-page":"665","volume":"133","author":"J Roth","year":"1994","unstructured":"Roth J, Ruzicka E, Mecir P (1994) Apomorphine test in differential diagnosis of parkinsonism. Casopis Lekaru Ceskych 133(21):665\u2013667","journal-title":"Casopis Lekaru Ceskych"},{"issue":"3","key":"12894_CR76","first-page":"326","volume":"123","author":"M Miranda","year":"1995","unstructured":"Miranda M, Saez D (1995) Assessment of dopaminergic response in parkinsons-disease using the apomorphine test. Rev Medica Chile 123(3):326\u2013329","journal-title":"Rev Medica Chile"},{"issue":"2","key":"12894_CR77","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1159\/000008142","volume":"43","author":"P Rossi","year":"2000","unstructured":"Rossi P, Colosimo C, Moro E, Tonali P, Albanese A (2000) Acute challenge with apomorphine and levodopa in Parkinsonism. Eur Neurol 43(2):95\u2013101. https:\/\/doi.org\/10.1159\/000008142","journal-title":"Eur Neurol"},{"issue":"1","key":"12894_CR78","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/s1353-8020(00)00083-3","volume":"8","author":"B Holmberg","year":"2001","unstructured":"Holmberg B, Johnels B, Ingvarsson P, Eriksson B, Rosengren L (2001) CSF-neurofilament and levodopa tests combined with discriminant analysis may contribute to the differential diagnosis of Parkinsonian syndromes. Parkinsonism Relat Disord 8(1):23\u201331. https:\/\/doi.org\/10.1016\/s1353-8020(00)00083-3","journal-title":"Parkinsonism Relat Disord"},{"issue":"4","key":"12894_CR79","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1002\/mds.10123","volume":"17","author":"M Merello","year":"2002","unstructured":"Merello M, Nouzeilles MI, Arce GP, Leiguarda R (2002) Accuracy of acute levodopa challenge for clinical prediction of sustained long-term levodopa response as a major criterion for idiopathic Parkinson\u2019s disease diagnosis. Mov Disord 17(4):795\u2013798. https:\/\/doi.org\/10.1002\/mds.10123","journal-title":"Mov Disord"},{"issue":"2","key":"12894_CR80","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1212\/01.wnl.0000130194.84594.96","volume":"63","author":"SB Bonelli","year":"2004","unstructured":"Bonelli SB, Ransmayr G, Steffelbauer M, Lukas T, Lampl C, Deibl M (2004) L-dopa responsiveness in dementia with Lewy bodies, Parkinson disease with and without dementia. Neurology 63(2):376\u2013378. https:\/\/doi.org\/10.1212\/01.wnl.0000130194.84594.96","journal-title":"Neurology"},{"issue":"9","key":"12894_CR81","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1136\/jnnp.2004.052332","volume":"76","author":"S Molloy","year":"2005","unstructured":"Molloy S, McKeith IG, O\u2019Brien JT, Burn DJ (2005) The role of levodopa in the management of dementia with Lewy bodies. J Neurol Neurosurg Psychiatry 76(9):1200\u20131203. https:\/\/doi.org\/10.1136\/jnnp.2004.052332","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"8","key":"12894_CR82","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.parkreldis.2010.06.004","volume":"16","author":"C Lucetti","year":"2010","unstructured":"Lucetti C, Logi C, Del Dotto P, Berti C, Ceravolo R, Baldacci F et al (2010) Levodopa response in dementia with lewy bodies: A 1-year follow-up study. Parkinsonism Relat Disord 16(8):522\u2013526. https:\/\/doi.org\/10.1016\/j.parkreldis.2010.06.004","journal-title":"Parkinsonism Relat Disord"},{"issue":"6","key":"12894_CR83","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.parkreldis.2012.03.017","volume":"18","author":"A Antonini","year":"2012","unstructured":"Antonini A, Vitale C, Barone P, Cilia R, Righini A, Bonuccelli U et al (2012) The relationship between cerebral vascular disease and parkinsonism: The VADO study. Parkinsonism Relat Disord 18(6):775\u2013780. https:\/\/doi.org\/10.1016\/j.parkreldis.2012.03.017","journal-title":"Parkinsonism Relat Disord"},{"issue":"3","key":"12894_CR84","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1111\/ane.12104","volume":"128","author":"S Asayama","year":"2013","unstructured":"Asayama S, Wate R, Kaneko S, Asayama T, Oki M, Tsuge A et al (2013) Levodopa challenge test and (123) I-metaiodobenzylguanidine scintigraphy for diagnosing Parkinson\u2019s disease. Acta Neurol Scand 128(3):160\u2013165. https:\/\/doi.org\/10.1111\/ane.12104","journal-title":"Acta Neurol Scand"},{"key":"12894_CR85","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3389\/fneur.2013.00095","volume":"4","author":"T Zackrisson","year":"2013","unstructured":"Zackrisson T, Bergquist F, Holmberg B, Johnels B, Thorlin T (2013) Evaluation of the objective posturo-locomotor-manual method in patients with parkinsonian syndromes. Front Neurol 4:95. https:\/\/doi.org\/10.3389\/fneur.2013.00095","journal-title":"Front Neurol"},{"issue":"2","key":"12894_CR86","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1007\/s00415-015-7961-7","volume":"263","author":"G Calandra-Buonaura","year":"2016","unstructured":"Calandra-Buonaura G, Doria A, Lopane G, Guaraldi P, Capellari S, Martinelli P et al (2016) Pharmacodynamics of a low subacute levodopa dose helps distinguish between multiple system atrophy with predominant Parkinsonism and Parkinson\u2019s disease. J Neurol 263(2):250\u2013256. https:\/\/doi.org\/10.1007\/s00415-015-7961-7","journal-title":"J Neurol"},{"issue":"5","key":"12894_CR87","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1002\/mdc3.12511","volume":"4","author":"S Schade","year":"2017","unstructured":"Schade S, Sixel-Doring F, Ebentheuer J, Schulz X, Trenkwalder C, Mollenhauer B (2017) Acute Levodopa challenge test in patients with de novo Parkinson\u2019s disease: data from the DeNoPa cohort. Mov Disord Clin Pract 4(5):755\u2013762. https:\/\/doi.org\/10.1002\/mdc3.12511","journal-title":"Mov Disord Clin Pract"},{"key":"12894_CR88","doi-asserted-by":"publisher","unstructured":"Alves Do Rego C, Namer IJ, Marcel C, Lefebvre F, Lagha-Boukbiza O, Renaud M, et al. Prospective study of relevance of (123)I-MIBG myocardial scintigraphy and clonidine GH test to distinguish Parkinson's disease and multiple system atrophy. J Neurol. 2018;265(9):2033\u20139. https:\/\/doi.org\/10.1007\/s00415-018-8941-5","DOI":"10.1007\/s00415-018-8941-5"},{"issue":"2","key":"12894_CR89","doi-asserted-by":"publisher","first-page":"430","DOI":"10.4103\/0028-3886.314539","volume":"69","author":"M Acharya","year":"2021","unstructured":"Acharya M, Banerjee S, Chatterjee A, Mukherjee A, Biswas S, Gangopadhyay G et al (2021) Predicting Long-Term Outcome of Patients of Early Parkinsonism with Acute Levodopa Challenge Test. Neurol India 69(2):430\u2013434. https:\/\/doi.org\/10.4103\/0028-3886.314539","journal-title":"Neurol India"},{"issue":"2","key":"12894_CR90","doi-asserted-by":"publisher","first-page":"811","DOI":"10.3233\/jpd-202262","volume":"11","author":"M Contin","year":"2021","unstructured":"Contin M, Lopane G, Cortelli P, Sambati L, Mohamed S, Calandra-Buonaura G (2021) Quantitative Assessment of Motor Response to a Low Subacute Levodopa Dose in the Differential Diagnosis of Parkinsonisms at Disease Onset: Data from the BoProPark Cohort. J Parkinsons Dis 11(2):811\u2013819. https:\/\/doi.org\/10.3233\/jpd-202262","journal-title":"J Parkinsons Dis"},{"issue":"1","key":"12894_CR91","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/mds.870070103","volume":"7","author":"JW Langston","year":"1992","unstructured":"Langston JW, Widner H, Goetz CG, Brooks D, Fahn S, Freeman T et al (1992) Core assessment program for intracerebral transplantations (CAPIT). Mov Disord 7(1):2\u201313. https:\/\/doi.org\/10.1002\/mds.870070103","journal-title":"Mov Disord"},{"issue":"4","key":"12894_CR92","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1002\/1531-8257(199907)14:4<572::aid-mds1005>3.0.co;2-c","volume":"14","author":"GL Defer","year":"1999","unstructured":"Defer GL, Widner H, Mari\u00e9 RM, R\u00e9my P, Levivier M (1999) Core assessment program for surgical interventional therapies in Parkinson\u2019s disease (CAPSIT-PD). Mov Disord 14(4):572\u2013584. https:\/\/doi.org\/10.1002\/1531-8257(199907)14:4%3c572::aid-mds1005%3e3.0.co;2-c","journal-title":"Mov Disord"},{"issue":"1","key":"12894_CR93","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1177\/0272989x8200200106","volume":"2","author":"S Greenfield","year":"1982","unstructured":"Greenfield S, Cretin S, Worthman LG, Dorey F (1982) The use of an ROC curve to express quality of care results. Med Decis Making 2(1):23\u201331. https:\/\/doi.org\/10.1177\/0272989x8200200106","journal-title":"Med Decis Making"},{"issue":"2","key":"12894_CR94","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1002\/mds.1069","volume":"16","author":"A Albanese","year":"2001","unstructured":"Albanese A, Bonuccelli U, Brefel C, Chaudhuri KR, Colosimo C, Eichhorn T et al (2001) Consensus statement on the role of acute dopaminergic challenge in Parkinson\u2019s disease. Mov Disord 16(2):197\u2013201. https:\/\/doi.org\/10.1002\/mds.1069","journal-title":"Mov Disord"},{"issue":"6","key":"12894_CR95","first-page":"429","volume":"3","author":"RH Roth","year":"1979","unstructured":"Roth RH (1979) Dopamine autoreceptors: pharmacology, function and comparison with post-synaptic dopamine receptors. Commun Psychopharmacol 3(6):429\u2013445","journal-title":"Commun Psychopharmacol"},{"key":"12894_CR96","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1749-6632.1984.tb14497.x","volume":"430","author":"RH Roth","year":"1984","unstructured":"Roth RH (1984) CNS dopamine autoreceptors: distribution, pharmacology, and function. Ann N Y Acad Sci 430:27\u201353. https:\/\/doi.org\/10.1111\/j.1749-6632.1984.tb14497.x","journal-title":"Ann N Y Acad Sci"},{"issue":"4414","key":"12894_CR97","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1126\/science.482929","volume":"206","author":"LR Skirboll","year":"1979","unstructured":"Skirboll LR, Grace AA, Bunney BS (1979) Dopamine auto- and postsynaptic receptors: electrophysiological evidence for differential sensitivity to dopamine agonists. Science 206(4414):80\u201382. https:\/\/doi.org\/10.1126\/science.482929","journal-title":"Science"},{"issue":"1","key":"12894_CR98","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1212\/wnl.52.1.120","volume":"52","author":"A Ekesbo","year":"1999","unstructured":"Ekesbo A, Rydin E, Torstenson R, Sydow O, L\u00e5engstr\u00f6m B, Tedroff J (1999) Dopamine autoreceptor function is lost in advanced Parkinson\u2019s disease. Neurology 52(1):120\u2013125. https:\/\/doi.org\/10.1212\/wnl.52.1.120","journal-title":"Neurology"},{"issue":"12","key":"12894_CR99","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1002\/mds.21126","volume":"21","author":"BG Clissold","year":"2006","unstructured":"Clissold BG, McColl CD, Reardon KR, Shiff M, Kempster PA (2006) Longitudinal study of the motor response to levodopa in Parkinson\u2019s disease. Mov Disord 21(12):2116\u20132121. https:\/\/doi.org\/10.1002\/mds.21126","journal-title":"Mov Disord"},{"issue":"8","key":"12894_CR100","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.parkreldis.2011.03.014","volume":"17","author":"E Anderson","year":"2011","unstructured":"Anderson E, Nutt J (2011) The long-duration response to levodopa: phenomenology, potential mechanisms and clinical implications. Parkinsonism Relat Disord 17(8):587\u2013592. https:\/\/doi.org\/10.1016\/j.parkreldis.2011.03.014","journal-title":"Parkinsonism Relat Disord"},{"issue":"3","key":"12894_CR101","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1002\/ana.410380308","volume":"38","author":"A Quattrone","year":"1995","unstructured":"Quattrone A, Zappia M, Aguglia U, Branca D, Colao R, Montesanti R et al (1995) The subacute levodopa test for evaluating long-duration response in Parkinson\u2019s disease. Ann Neurol 38(3):389\u2013395. https:\/\/doi.org\/10.1002\/ana.410380308","journal-title":"Ann Neurol"},{"issue":"8","key":"12894_CR102","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1212\/wnl.45.8.1613","volume":"45","author":"JG Nutt","year":"1995","unstructured":"Nutt JG, Carter JH, Woodward WR (1995) Long-duration response to levodopa. Neurology 45(8):1613\u20131616. https:\/\/doi.org\/10.1212\/wnl.45.8.1613","journal-title":"Neurology"},{"issue":"6","key":"12894_CR103","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1002\/ana.10189","volume":"51","author":"JG Nutt","year":"2002","unstructured":"Nutt JG, Carter JH, Lea ES, Sexton GJ (2002) Evolution of the response to levodopa during the first 4 years of therapy. Ann Neurol 51(6):686\u2013693. https:\/\/doi.org\/10.1002\/ana.10189","journal-title":"Ann Neurol"},{"issue":"2","key":"12894_CR104","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1002\/ana.410420217","volume":"42","author":"M Zappia","year":"1997","unstructured":"Zappia M, Colao R, Montesanti R, Rizzo M, Aguglia U, Gambardella A et al (1997) Long-duration response to levodopa influences the pharmacodynamics of short-duration response in Parkinson\u2019s disease. Ann Neurol 42(2):245\u2013248. https:\/\/doi.org\/10.1002\/ana.410420217","journal-title":"Ann Neurol"},{"issue":"8","key":"12894_CR105","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1038\/s41591-023-02440-2","volume":"29","author":"AK Schalkamp","year":"2023","unstructured":"Schalkamp AK, Peall KJ, Harrison NA, Sandor C (2023) Wearable movement-tracking data identify Parkinson\u2019s disease years before clinical diagnosis. Nat Med 29(8):2048\u20132056. https:\/\/doi.org\/10.1038\/s41591-023-02440-2","journal-title":"Nat Med"},{"issue":"10","key":"12894_CR106","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1038\/s41591-022-01932-x","volume":"28","author":"Y Yang","year":"2022","unstructured":"Yang Y, Yuan Y, Zhang G, Wang H, Chen YC, Liu Y et al (2022) Artificial intelligence-enabled detection and assessment of Parkinson\u2019s disease using nocturnal breathing signals. Nat Med 28(10):2207\u20132215. https:\/\/doi.org\/10.1038\/s41591-022-01932-x","journal-title":"Nat Med"},{"issue":"4","key":"12894_CR107","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e14824","volume":"9","author":"M Beli\u0107","year":"2023","unstructured":"Beli\u0107 M, Radivojevi\u0107 Z, Bobi\u0107 V, Kosti\u0107 V, \u0110uri\u0107-Jovi\u010di\u0107 M (2023) Quick computer aided differential diagnostics based on repetitive finger tapping in Parkinson\u2019s disease and atypical parkinsonisms. Heliyon 9(4):e14824. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e14824","journal-title":"Heliyon"},{"key":"12894_CR108","doi-asserted-by":"publisher","unstructured":"Varghese J, Alen CMV, Fujarski M, Schlake GS, Sucker J, Warnecke T, et al. Sensor Validation and Diagnostic Potential of Smartwatches in Movement Disorders. Sensors (Basel). 2021;21(9). https:\/\/doi.org\/10.3390\/s21093139","DOI":"10.3390\/s21093139"},{"issue":"6","key":"12894_CR109","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1002\/mds.29005","volume":"37","author":"GK Wenning","year":"2022","unstructured":"Wenning GK, Stankovic I, Vignatelli L, Fanciulli A, Calandra-Buonaura G, Seppi K et al (2022) the movement disorder society criteria for the diagnosis of multiple system atrophy. Mov Disord 37(6):1131\u20131148. https:\/\/doi.org\/10.1002\/mds.29005","journal-title":"Mov Disord"},{"issue":"6","key":"12894_CR110","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1002\/mds.26987","volume":"32","author":"GU H\u00f6glinger","year":"2017","unstructured":"H\u00f6glinger GU, Respondek G, Stamelou M, Kurz C, Josephs KA, Lang AE et al (2017) Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria. Mov Disord 32(6):853\u2013864. https:\/\/doi.org\/10.1002\/mds.26987","journal-title":"Mov Disord"},{"issue":"2","key":"12894_CR111","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0172145","volume":"12","author":"R Vasta","year":"2017","unstructured":"Vasta R, Nicoletti A, Mostile G, Dibilio V, Sciacca G, Contrafatto D et al (2017) Side effects induced by the acute levodopa challenge in Parkinson\u2019s Disease and atypical parkinsonisms. PLoS ONE 12(2):e0172145. https:\/\/doi.org\/10.1371\/journal.pone.0172145","journal-title":"PLoS ONE"},{"key":"12894_CR112","doi-asserted-by":"publisher","first-page":"1293732","DOI":"10.3389\/fneur.2023.1293732","volume":"14","author":"M Tamura","year":"2023","unstructured":"Tamura M, Takeda T, Kitayama Y, Suichi T, Shibuya K, Harada-Kagitani S et al (2023) Neuropathological features of levodopa-responsive parkinsonism in multiple system atrophy: an autopsy case report and comparative neuropathological study. Front Neurol 14:1293732. https:\/\/doi.org\/10.3389\/fneur.2023.1293732","journal-title":"Front Neurol"},{"issue":"11","key":"12894_CR113","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1007\/s00259-010-1520-3","volume":"37","author":"SJ Mo","year":"2010","unstructured":"Mo SJ, Linder J, Forsgren L, Larsson A, Johansson L, Riklund K (2010) Pre- and postsynaptic dopamine SPECT in the early phase of idiopathic parkinsonism: a population-based study. Eur J Nucl Med Mol Imaging 37(11):2154\u20132164. https:\/\/doi.org\/10.1007\/s00259-010-1520-3","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"8","key":"12894_CR114","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1093\/brain\/awaa226","volume":"143","author":"W Poewe","year":"2020","unstructured":"Poewe W, Espay AJ (2020) Long duration response in Parkinson\u2019s disease: levodopa revisited. Brain 143(8):2332\u20132335. https:\/\/doi.org\/10.1093\/brain\/awaa226","journal-title":"Brain"},{"issue":"6","key":"12894_CR115","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s00702-003-0815-y","volume":"110","author":"T M\u00fcller","year":"2003","unstructured":"M\u00fcller T, Benz S, B\u00f6rnke C, Russ H, Przuntek H (2003) Repeated rating improves value of diagnostic dopaminergic challenge tests in Parkinson\u2019s disease. J Neural Transm (Vienna) 110(6):603\u2013609. https:\/\/doi.org\/10.1007\/s00702-003-0815-y","journal-title":"J Neural Transm (Vienna)"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-12894-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-025-12894-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-12894-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T16:41:09Z","timestamp":1739637669000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-025-12894-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":115,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["12894"],"URL":"https:\/\/doi.org\/10.1007\/s00415-025-12894-8","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"13 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Nothing to report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Financial disclosures"}}],"article-number":"176"}}